HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).

Abstract
An abnormal fibrinogen, denoted as 'fibrinogen Milano IV', has been found in a 36-year-old woman without any bleeding manifestations or thrombotic tendency. Routine coagulation studies revealed prolonged thrombin and reptilase clotting times, very low plasma fibrinogen concentration determined by the functional assay but a normal fibrinogen concentration measured by the immunologic assay. Turbidity curves, measured following addition of thrombin to purified fibrinogen Milano IV, both in presence of calcium or EDTA, were markedly delayed. Release of fibrinopeptide B by thrombin was normal, whereas only half the normal amount of fibrinopeptide A was cleaved. The fibrinopeptide A peak of fibrinogen was preceded by an abnormal fibrinopeptide A*. Both peaks were collected for amino acid analysis which showed an exchange of arginine by histidine in position 16 of the A alpha chain of the fibrinopeptide A*.
AuthorsC Bögli, A Hofer, F Baudo, R Redaelli, M Furlan
JournalHaemostasis (Haemostasis) Vol. 22 Issue 1 Pg. 7-11 ( 1992) ISSN: 0301-0147 [Print] Switzerland
PMID1521828 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amino Acids
  • Fibrinogens, Abnormal
  • fibrinogen Milano IV
  • Fibrinopeptide A
  • Thrombin
Topics
  • Abortion, Spontaneous (etiology)
  • Adult
  • Afibrinogenemia (blood, complications, congenital, genetics)
  • Amino Acids (analysis)
  • Blood Coagulation Tests
  • Female
  • Fibrinogens, Abnormal (genetics, isolation & purification)
  • Fibrinopeptide A (metabolism)
  • Humans
  • Pregnancy
  • Thrombin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: